Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
FluidForm Biofluidformbio.com · Low evidenceFluidForm Bio develops FRESH 3D bioprinting technology to create implantable, vascularized tissue constructs that support the long-term survival and function of therapeutic cells. The approach yields minimally invasive, easily retrievable implants with dense vascularization just under the skin, forming a platform for complex tissue engineering. By combining synthetic biology, 3D printing, advanced materials, and AI, FRESH provides a platform to engineer tissues that thrive in the body.
Sources
pmc.ncbi.nlm.nih.gov shapes more of what AI says about FluidForm Bio than any other source, at 40% of its citations.
google.com · lulzbot.com · sciencedaily.com
The market map
Specialized Professional Tools and Services →Where AI ranks FluidForm Bio